Menopausal weight gain is common, driven by hormonal changes and decreased muscle mass and energy expenditure. Hormone therapy is weight neutral and should not be used for weight loss; it may help with vasomotor symptoms. Treating vasomotor symptoms, sleep disturbance, and mood disorders can remove barriers to weight loss for women during menopause, experts say.
Clinical Case Highlight
Salma, a 52-year-old woman who is 2 years past her final menstrual period, is frustrated. She walks daily, counts calories, and has never struggled with belly fat until now. Despite maintaining her routine, she has gained 10 pounds over the past year and asks her clinician if hormone therapy can help.
“She asks you the bombshell question because she’s been on social media and she thinks pharmacotherapy can help her melt the belly fat,” said Ekta Kapoor, MBBS, FACP, MSCP, associate professor of medicine at Mayo Clinic College of Medicine. “Hormone therapy can actually result in weight gain. It’s best avoided.”
Besides highlighting the need for better patient education on treatment types, Salma’s question also captures a common midlife concern: many women feel they are “doing everything right” but still gain weight as menopause progresses. The appropriate response, Kapoor said, is to not dismiss the concern but rather investigate the underlying symptoms that may be sabotaging healthy habits, such as sleep loss, hot flashes, and mood changes.
At The Menopause Society 2025 Annual Meeting, Kapoor explained how menopause symptoms can directly interfere with weight-management efforts and why lifestyle modification remains the foundation of care.
How Common Is Weight Gain During Menopause?
In a Mayo Clinic survey of nearly 5,000 women aged 45 to 60 years, weight gain was cited as the most frequent concern, reported by about 80% of participants, followed by sleep problems, exhaustion, and hot flashes.
“Weight gain is a very common concern in midlife women; it has been studied for a long time,” Kapoor noted. “Seven out of 10 women going through midlife, through the menopause transition, will have either overweight or obesity.”
Midlife women gain an average of 0.4 to 0.7 kg per year, driven largely by a decline in muscle mass and energy expenditure that accompanies aging. There are also changes in body composition during the menopausal transition that are linked to hormonal shifts, including increased visceral and abdominal fat and decreased lean tissue and bone mass. This can occur even if the scale shows little change, and the composition can worsen despite stable weight.
These changes can feel disproportionate to lifestyle habits, leaving women discouraged. Kapoor emphasized that addressing other bothersome symptoms of menopause can make weight management more feasible.
Treating Symptoms That Prevent Lifestyle Change
The first step is eating in a calorie deficit. Kapoor typically advises a 500-calorie daily deficit, translating to roughly 1300–1500 calories per day for many midlife women. “Calorie restriction is key,” she stated plainly. “Unless there is calorie restriction happening, weight gain is inevitable.”
Physical activity should be encouraged for its mental and metabolic benefits, but excessive all-or-nothing thinking can undermine progress. Even modest activity supports body composition, mood, and sleep quality. “Something is better than nothing,” Kapoor advised, warning against lofty goals that set patients up for disappointment.
Symptoms such as vasomotor instability, sleep disturbance, and anxiety can make adherence to a calorie deficit and regular exercise difficult. Clinicians should identify which symptom cluster—hot flashes, poor sleep, or mood disorders—is most disruptive, and treatment should follow that hierarchy. When vasomotor symptoms are prominent, hormone therapy can be considered as first-line for eligible women.
“Estrogen-based hormone therapy is the most effective for treatment of vasomotor symptoms, assuming there is no contraindication, but there is no direct effect on weight,” Kapoor explained. “Hormone therapy is to be considered weight neutral. Indirect benefits may occur if symptoms improve, but there is no direct weight effect.”
If hormone therapy is contraindicated, nonhormonal approaches such as cognitive behavioral therapy and clinical hypnosis have strong evidence. Among pharmacologic options, weight-neutral or weight-favorable agents—venlafaxine, desvenlafaxine, oxybutynin, or fezolinetant—are preferred, while drugs like paroxetine, gabapentin, or escitalopram may promote weight gain and should be avoided when possible.
Can Sleep Help Women Control Weight?
Sleep disturbances affect roughly 70% of women during menopause and can occur even without hot flashes. Clinicians often underestimate this issue, noting that two-thirds of women with increased wakefulness do not experience vasomotor symptoms. This distinction matters for management because sleep issues impact weight through metabolic signaling and appetite regulation.
Poor sleep contributes to weight gain by disrupting ghrelin and leptin signaling, increasing daily energy intake by 250 kcal or more. Chronic sleep deprivation of fewer than 5 hours per night is linked to a 32% higher risk of major weight gain over time.
For women whose main complaint is sleep disruption, clinicians should screen for obstructive sleep apnea even when classic symptoms are absent. Cognitive behavioral therapy for insomnia is a first-line option. Hormones may help when hot flashes drive sleep disruption, but they have limited benefit when vasomotor symptoms are absent.
Practical Implications for Practice
To optimize weight management during menopause, clinicians should:
- Assess and address the most disruptive symptom cluster first, prioritizing vasomotor symptoms management when indicated.
- Promote a sustainable calorie deficit and realistic physical activity goals tailored to individual capacity and preferences.
- Consider weight-neutral pharmacologic options when pharmacotherapy is appropriate, avoiding agents with potential weight gain.
- Screen for sleep disorders, particularly obstructive sleep apnea, and implement evidence-based sleep interventions.
Overall, weight management during menopause hinges on addressing symptom burden, optimizing sleep, and implementing sustainable lifestyle strategies, with hormone therapy playing a nuanced, individualized role for vasomotor control rather than weight loss.
Related topics
